发明授权
- 专利标题： Solid state forms of a potent HCV inhibitor
- 专利标题（中）： 固态形式的有效的HCV抑制剂
-
申请号： US13241551申请日： 2011-09-23
-
公开(公告)号： US08598183B2公开(公告)日： 2013-12-03
- 发明人: Rolf-Stefan Brickl , Shirlynn Chen , Jihchin Chung , Mayur Suryakant Dudhedia , Danping Li , Zhi-Hui Lu , Siddharthya Mujumdar , Chitra Telang , Richard J. Varsolona , Zeren Wang
- 申请人： Rolf-Stefan Brickl , Shirlynn Chen , Jihchin Chung , Mayur Suryakant Dudhedia , Danping Li , Zhi-Hui Lu , Siddharthya Mujumdar , Chitra Telang , Richard J. Varsolona , Zeren Wang
- 申请人地址： DE Ingelheim am Rhein
- 专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人地址： DE Ingelheim am Rhein
- 代理商 Michael P. Morris; Philip I. Datlow
- 主分类号： C07D235/04
- IPC分类号： C07D235/04
摘要：
This invention relates to novel sodium salt forms of the following Compound (1), and methods for the preparation thereof, pharmaceutical compositions thereof, and their use in the treatment of Hepatitis C Viral (HCV) infection:
公开/授权文献
- US20120122887A1 SOLID STATE FORMS OF A POTENT HCV INHIBITOR 公开/授权日：2012-05-17
信息查询
